Urogen Pharma

URGN · NASDAQ

$35.01+$0.86 (+2.52%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $34.15

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. The firm is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).

Employees: 298
Headquarters: Ra'anana
Listed: May 4, 2017
Sector: Health Care
Industry: Biotechnology
Website: urogen.com

Leadership

Urogen Pharma executives
Name	Title	Since	Age
Arie Belldegrun	—	—	75
Elizabeth Barrett	—	2019	62
Christopher Degnan	—	—	45
Jason Smith	—	—	53
Mark Schoenberg	—	—	67
Cynthia Butitta	—	—	70
Stuart Holden	—	—	82
James Robinson	—	—	55
Leana Wen	—	—	42
Daniel Wildman	—	—	68
Vincent Perrone	—	2022	—

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Urogen Pharma suppliers and customers
Company	Relationship	Country	Correlation
Agenus AGEN	Supplier and customer	US	0.90
Teva Pharmaceutical Inds TEVA	Supplier	IL	0.62
AbbVie ABBV	Supplier and customer	US	-0.84
Johns Hopkins University	Supplier and customer	US	—
University of Texas M.D. Anderson Cancer Center	Supplier and customer	US	—
Isotopia Molecular Imaging Ltd.	Supplier	IL	—
Neopharm Ltd.	Supplier and customer	IL	—
Phinex SAS	Supplier	FR	—

Similar companies

Companies in the same industry as Urogen Pharma

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.